# Impact of Estrogen + Estradiol Receptor Alpha Modulator Therapy on Oxidative Stress in Post-menopausal Women With and Without Sleep Apnea

> **NCT03981341** · PHASE3 · UNKNOWN · sponsor: **Laval University** · enrollment: 36 (estimated)

## Conditions studied

- Sleep Apnea
- Post Menopausal
- Oxidative Stress

## Interventions

- **DRUG:** Duavive (0.45 estrogens mg and 20 mg bazedoxifene)

## Key facts

- **NCT ID:** NCT03981341
- **Lead sponsor:** Laval University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-11-01
- **Primary completion:** 2023-12-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2022-04-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03981341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03981341, "Impact of Estrogen + Estradiol Receptor Alpha Modulator Therapy on Oxidative Stress in Post-menopausal Women With and Without Sleep Apnea". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT03981341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*